Every like, comment, or share you give is a sign of support. I'm Gao Daxia, a self-media person obsessed with Hong Kong stock new issues. I have long been focused on the upstream and downstream industrial chain of the Hong Kong stock new issue market, from PRE-IPO to cornerstone national allocation funds for new shares to retail groups A and B participating in new issues. I enjoy communicating with like-minded friends. If you like my content, please follow me! You can find me under the same name across the web: Gao Daxia Talks New Shares
Hong Kong Stock New Issue IPO | MicroTech Medical~B (02235:HK) goes public in Hong Kong
① MicroTech Medical~B Fundamental Analysis Introduction
② MicroTech Medical~B Offering Information Overview (Offer Price, Industry Analysis, Sponsor, Underwriters, etc.)
③ MicroTech Medical~B Comprehensive Review by Expert
① | MicroTech Medical~B (02235:HK) Fundamentals
MicroTech Medical was founded in 2011 and primarily focuses on diabetes management, providing medical devices for diabetes treatment and monitoring to optimize diabetes management in China and globally.
MicroTech Medical's core product, the Equil Patch Insulin Pump System (“Equil”), is a semi-disposable patch insulin pump. Equil received the CE mark in Europe in June 2017 and obtained NMPA approval for adult use in China in September 2017. In China, Equil is classified as a Class III medical device. In 2018, we began commercializing Equil in China and Europe. Additionally, we are seeking to expand Equil’s indications for use among children and adolescents...